Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic Value Against Prostate Cancer by Molecular Docking Study

Mohammad Mijanur Rahman 1 , *
Author Information
1 Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 2015, 10 (1); e59673
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: February 13, 2014
  • Accepted: May 12, 2014
  • DOI: 10.17795/jjnpp-18216

To Cite: Rahman M M. Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic Value Against Prostate Cancer by Molecular Docking Study, Jundishapur J Nat Pharm Prod. 2015 ; 10(1):e59673. doi: 10.17795/jjnpp-18216.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
References
  • 1. Sriram D, Yogeeswari P. Medicinal Chemistry. 2010;
  • 2. Matsumoto T, Sakari M, Okada M, Yokoyama A, Takahashi S, Kouzmenko A, et al. The androgen receptor in health and disease. Annu Rev Physiol. 2013; 75: 201-24[DOI][PubMed]
  • 3. Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002; 20(13): 3001-15[PubMed]
  • 4. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol. 2002; 16(10): 2181-7[DOI][PubMed]
  • 5. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004; 25(2): 276-308[DOI][PubMed]
  • 6. Lonergan PE, Tindall DJ. Androgen receptor signaling in prostate cancer development and progression. J Carcinog. 2011; 10: 20[DOI][PubMed]
  • 7. Lee E, Madar A, David G, Garabedian MJ, Dasgupta R, Logan SK. Inhibition of androgen receptor and beta-catenin activity in prostate cancer. Proc Natl Acad Sci U S A. 2013; 110(39): 15710-5[DOI][PubMed]
  • 8. Nareeboon P, Komkhunthot W, Lekcharoen D, Wetprasit N, Piriyapolsart C, Sutthivaiyakit S. Acetylenic fatty acids, triglyceride and triterpenes from the leaves of Hymenodictyon excelsum. Chem Pharm Bull (Tokyo). 2009; 57(8): 860-2[PubMed]
  • 9. Rao PS, Asheervadam Y, Khaleelullah M, Rao NS, Murray RD. Hymexelsin, an Apiose-Containing Scopoletin Glycoside from the Stem Bark of Hymenodictyon excelsum. J Nat Prod. 1988; 51(5): 959-61[DOI][PubMed]
  • 10. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants.
  • 11. Kar B, Nepal A, Kumar RBS, Dolai N, Bhattacharya S, Mazumder UK, et al. Antioxidant and anti-inflammatory properties Hymenodictyon excelsum bark. Orient Pharm Exp Med. 2013; 13(2): 103–111
  • 12.
  • 13.
  • 14.
  • 15. Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006; 49(11): 3315-21[DOI][PubMed]
  • 16. Biljali S, Hadjimitova VA, Topashka-Ancheva MN, Momekova DB, Traykov TT, Karaivanova MH. Antioxidant and antiradical properties of esculin, and its effect in a model of epirubicin-induced bone marrow toxicity. Folia Med (Plovdiv). 2012; 54(3): 42-9[PubMed]
  • 17. Nawab A, Yunus M, Mahdi AA, Gupta S. Evaluation of anticancer properties of medicinal plants from the Indian sub-continent. Mol Cellular Pharmacol. 2011; 3(1): 21-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments